AtriCure (ATRC) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $31.79 +6.93%
Revenue Growth %: +11.6%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
CRMT, More
Revenue Growth %: +11.6%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $45.2 million versus the consensus estimate of $44.21 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
- AtriCure to Announce Second Quarter 2026 Financial Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
